ProMIS Neurosciences Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -62.8% | -9.8% | +6.9% | -7.7% | +74.8% | +83.7% | +195.4% | -67.6% | +40.4% | -100.0% | – | |
| – | -22.8% | +5.9% | +29.8% | +42.9% | -18.0% | -36.0% | +24.4% | +27.1% | -58.6% | +204.1% | +3.9% | |
| – | – | – | – | – | -39.8% | -36.0% | +240.4% | -427.9% | – | – | – | |
| – | – | – | -187.8% | – | +153.5% | -4.5% | -302.1% | – | -59.4% | -498.3% | – | |
| – | -100.0% | – | -100.0% | – | +1,993,771.6% | +0.0% | -94.4% | -56.5% | -100.0% | – | – | |
| – | +1,378.7% | -99.5% | +7.2% | -7.4% | +37.7% | +53,686.5% | – | -102.8% | -49.3% | -48.6% | +1.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | -100.0% | – | – | – | |
| – | +42.3% | -2.5% | +203.3% | +29.2% | -21.8% | -28.5% | +568.5% | -66.0% | +103.4% | +57.1% | -24.9% | |
| – | +2,547.5% | -122.5% | – | -33.9% | -241.7% | – | – | -192.0% | – | -89.7% | -1,135.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.